期刊文献+

非RGD肽超微超顺磁氧化铁探针制备及对人脐静脉内皮细胞的靶向作用 被引量:1

Preparation of non RGD peptide conjugated ultrasmall superparamagnetic iron particles and its targeting effect on human umbilical vein endothelial cells
下载PDF
导出
摘要 目的:构建非RGD肽-超微超顺磁氧化铁(USPIO)分子探针,探讨其对人脐静脉内皮细胞(HUVEC)的靶向作用。方法:采用化学交联法将非RGD肽(命名为P1c)偶联于二巯基丁二酸(DMSA)修饰的USPIO,形成具有免疫活性的分子探针。采用细胞计数试剂盒(CCK-8)检测探针对HUVEC增殖的影响。USPIO标记的P1c肽作为实验组,USPIO为对照组,通过固相结合实验、普鲁士蓝染色分析其体外免疫学特性,采用1.5 T磁共振仪对探针与高表达整合素αvβ3的HUVEC进行体外细胞成像。结果:成功构建USPIO标记的P1c肽分子探针,其对HUVEC增殖无明显影响。固相结合实验及普鲁士蓝染色证实该探针能特异性与整合素αvβ3结合。体外MRI显示在同一铁质量浓度时,P1c-USPIO与HUVEC孵育后较USPIO组T2*值明显缩短。结论:化学交联法可成功制备P1c肽USPIO分子探针,该分子探针具有良好免疫学活性,可特异性结合整合素αvβ3分子。 Objective: To develop an ultrasmall superparamagnetic iron oxide(USPIO) based MR probe containing non RGD peptide(named P1c) and investigate its targeting effect on Human umbilical vein endothelial cells(HUVECs).Methods: To prepare immunologically competent probe,P1c was conjugated with USPIO coated with meso-2,3-dimercaptosuccinic acid(DMSA).Cell counting kit-8 assay was conducted to ascertain the probe’s effect on the HUVECs’ growth.The USPIO labeled P1c peptide was experimental group,and the USPIO was control group.The solid phase binding assay and Prussian blue staining were employed to evaluate the immunocompetence of P1c-USPIO.The probe’s cell MR imaging in vitro was performed using HUVECs with high integrin αvβ3 expression.Results: The P1c-USPIO was constructed.The probe had no effect on the growth of HUVECs.The solid phase binding assay and Prussian blue staining showed that the probe could bind with integrin αvβ3 on HUVECs with high specificity.MR cell imaging in vitro demonstrated that at the same mass concentration of iron the T2* value in P1c-USPIO group was much shorter than it in USPIO group.Conclusion: The molecular probe P1c-USPIO could be prepared successfully using chemical cross linking method.The P1c-USPIOs remained their immunocompetence.The probe could specifically bind with HUVECs.
出处 《江苏大学学报(医学版)》 CAS 2013年第2期99-102,107,共5页 Journal of Jiangsu University:Medicine Edition
基金 国家自然科学基金资助项目(30970809)
关键词 多肽 分子探针 整合素 内皮细胞 peptide molecular probe integrin endothelial cells
  • 相关文献

参考文献12

  • 1Saraste A, Laitinen I, Weidl E, et al. Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer ^18F- galacto-RGD in mouse atherosclerotic plaques [ J ]. J Nucl Cardiol, 2012, 19(4) :775 -784.
  • 2Laitinen I, Saraste A, Weidl E, et al. Evaluation of al- phavbeta3 integrin-targeted positron emission tomography tracer ^18 F-galacto-RGD for imaging of vascular inflamma- tion in atherosclerotic mice [ J ]. Circ Cardiovasc Ima- ging, 2009, 2(4):331 -338.
  • 3Waldeck J, Hager F, Hohke C, et al. Fluorescence re- flectance imaging of macrophage-rich atherosclerotic plaques using an alphavbet% integrin-targeted fluoro- chrome[J]. J Nucl Med, 2008, 49(11) :1845 - 1851.
  • 4Wolf G, Abolmaali N. Preclinical molecular imaging u- sing PET and MRI [ J ]. Recent Results Cancer Res, 2013, 187:257-310.
  • 5耿兴东,单秀红,熊非,顾宁.葡萄糖受体介导的肿瘤靶向2-DG修饰超顺磁性氧化铁的制备及体外实验[J].山东医药,2012,52(11):1-4. 被引量:8
  • 6张伟,蔡亮,陈跃,黄占文,尹平.^(99m)Tc-Gd-DTPA-DG合成及宫颈癌细胞对其摄取的研究[J].山东医药,2010,50(23):17-19. 被引量:4
  • 7Beer AJ, Schwaiger M. Imaging of integrin alphavbeta3 expression[ J]. Cancer Metastasis Rev, 2008, 27 (4) : 531 -644.
  • 8Bogdanowich-Knipp SJ, Chakrabarti S, Williams TD, et al. Solution stability of linear vs. cyclic RGD peptides [J]. JPeptRes, 1999, 53(5):530 -541.
  • 9Assa-Munt N, Jia X, Laakkonen P, et al. Solution structures and integrin binding activities of an RGD pep- tide with two isomers [ J ]. Biochemistry,2001, 40 (8) : 2373 - 2378.
  • 10罗先富,吴晶涛,胡晓华,瞿秋霞,叶靖,陈明祥,陈文新,王守安,董颖,王军.CD40突变体靶向MR分子成像探针制备及体外卵巢癌成像的实验研究[J].中华放射学杂志,2012,46(3):264-268. 被引量:5

二级参考文献25

  • 1Kennedy DC,Duguay DR,Tay LL,et al.SERS detection and boron delivery to cancer cells using carborane labelled nanoparticles[J].Chem Commun (Camb),2009,28(44):6750-6752.
  • 2Wadas TJ,Deng H,Sprague JE,et al.Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases[J].J Nucl Med,2009,50(11):1873-1880.
  • 3Lee S,Chen X.Dual-modality probes for in vivo molecular imaging[J].Mol Imaging,2009,8(2):87-100.
  • 4Lijowski M,Caruthers S,Hu G,et al,High sensitivity:high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model[J].Invest Radiol,2009,44(1):15-22.
  • 5Liang J,Chen Y,Huang Z,et al.Early chemotherapy response evaluation in tumors by 99mTc-DTPA-DG[J].Cancer Biother Radiopharm,2008,23(3):363-370.
  • 6Nahrendorf M,Zhang H,Hembrador S,et al.Nanoparticle PET-CT imagine of macrophages in inflammatory atherosclerosis[J].Circulation,2008,117(3):379-387.
  • 7Leuschner C,Kumar CS,Hansel W. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases[J].Breast Cancer Research and Treatment,2006,(02):163-176.
  • 8Maublant J,Vuillez JP,Talbot JN. Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology[J].Bulletin Du Cancer,1998,(11):935-950.
  • 9Mosmann T. Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays[J].Journal of Immunological Methods,1983,(1-2):55-63.doi:10.1016/0022-1759(83)90303-4.
  • 10Shan XH,Hu H,Xiong F. Targeting Glutl-overexpressing MDA-MB-231 cells with 2-deoxy-D-glucose modified SPIOs[J].European Journal of Radiology,2012,(01):95-99.

共引文献12

同被引文献14

  • 1El-Scrag H B. Epidemiology of viral hepatitis and hepatocellular carcinoma[J]. Gastroenterology, 2012,142(6) : 1264- 1273.
  • 2Chen M, Therneau T, Orsini L S, et al. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multieenter co- hort trial in hepatocellular carcinoma [J]. BMC Gastroenterol, 2011,11(1) :53-59.
  • 3Chaudary N, Milosevic M, Hill R P. Suppression of vascular en- dothelial growth factor receptor 3 (VEGFR3) and vascular endo- thelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer [J], Gynecologic Oneol, 2011, 123(2) :393-400.
  • 4Hong K D, Lee Y, Kim B H, et al. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in eolorectal cancer[J]. Am Surg, 2013,79 (2) : 198- 204.
  • 5Rode A. Radiological diagnosis of hepatocellular carcinoma in 2010 [J]. Cancer Radiother,2011,15(1) :7-12.
  • 6Sanvicens N, Marco M P. Muhifunctional nanoparticales-proper- ties and prospects for their use in human medicine[J]. Trends Biotechnol, 2008,26 (8) : 425 -433.
  • 7Saar B, Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma[J]. Liver Int, 2008,28(2) : 189- 199.
  • 8Jayapaul J,Arns S, Lederle W, et al. Riboflavin carrier protein- targeted fluorescent USPIO for the assessment of vascular metab- olism in tumors [J]. Biomaterials, 2012, 33(34) :8822-8829.
  • 9Gou H F, Chen X C, Zhu J, et al. Expressions of COX-2 and VEGF- C in gastric cancer: correlations with lyrnphangiogenesis and prognostic implications[J]. J Exp Clin Cancer Res, 2011,30:14.
  • 10Zhao Y C, Ni X J, Li Y, et al. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lyraph node metastasis in breast cancer patients[J]. World J Surgi Oncol, 2012, 10:165.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部